[1]
“Repurposing the Antiparasitic Agent Praziquantel for Breast Neoplasm Therapy: A Narrative Review of the Mechanistic Rationale, Current Evidence and Translational Barriers”, J. Can. Res. Updates, vol. 15, no. 3, pp. 292–302, Sep. 2026, doi: 10.30683/1929-2279.2026.15.26.